145 related articles for article (PubMed ID: 2150190)
1. Renal effects of the new calcium channel blocking drug isradipine.
Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
[TBL] [Abstract][Full Text] [Related]
3. Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine.
Krusell LR; Jespersen LT; Schmitz A; Thomsen K; Pedersen OL
Hypertension; 1987 Dec; 10(6):577-81. PubMed ID: 2447016
[TBL] [Abstract][Full Text] [Related]
4. Effect of isradipine on renal haemodynamics and systemic blood pressure changes induced by intravenous infusion of endothelin in healthy humans.
Sørensen SS; Jensen JD; Madsen JK; Pedersen EB
Nephrol Dial Transplant; 1995; 10(8):1324-31. PubMed ID: 8538922
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism.
Francischetti EA; Barroso I; da Silva A; Fagundes VG
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of isradipine on blood pressure and renal function.
Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K
Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650
[TBL] [Abstract][Full Text] [Related]
7. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.
Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA
Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765
[TBL] [Abstract][Full Text] [Related]
8. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
Persson B; Wysocki M; Andersson OK
J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
[TBL] [Abstract][Full Text] [Related]
9. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects.
Moulin B; Fillastre JP; Godin M; Coquerel A; Decoopman E
J Cardiovasc Pharmacol; 1995 Feb; 25(2):292-9. PubMed ID: 7752655
[TBL] [Abstract][Full Text] [Related]
10. Effects of isradipine on hypertension and renal hemodynamics.
Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846
[TBL] [Abstract][Full Text] [Related]
11. Renal and hemodynamic effects of isradipine in essential hypertension.
Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M
Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657
[TBL] [Abstract][Full Text] [Related]
12. The calcium antagonist isradipine and its effect on blood pressure related to plasma renin activity.
Carr AA; Prisant LM
Am J Hypertens; 1990 May; 3(5 Pt 1):354-9. PubMed ID: 2140943
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
Allikmets K; Parik T; Teesalu R
Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of isradipine in essential hypertension.
Grossman E; Messerli FH; Oren S; Nunez B; Garavaglia GE
Am J Cardiol; 1991 Jul; 68(1):65-70. PubMed ID: 1829320
[TBL] [Abstract][Full Text] [Related]
15. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
Nagao T; Yamaguchi I; Narita H; Nakajima H
Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
[TBL] [Abstract][Full Text] [Related]
17. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose nifedipine on urinary protein excretion rate in patients with renal disease.
Kloke HJ; Wetzels JF; Koene RA; Huysmans FT
Nephrol Dial Transplant; 1998 Mar; 13(3):646-50. PubMed ID: 9550641
[TBL] [Abstract][Full Text] [Related]
19. Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
Wittenberg C; Rosenfeld JB
Am J Hypertens; 1991 Feb; 4(2 Pt 2):191S-193S. PubMed ID: 1827019
[TBL] [Abstract][Full Text] [Related]
20. Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria.
Persson B; Andersson OK; Wysocki M; Hedner T; Karlberg B
J Intern Med; 1992 Mar; 231(3):247-52. PubMed ID: 1532613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]